The Cancer Care Crisis
-
Over 4 million cancer cases annually in the EU by 2025.
-
Radiotherapy is essential for over 50% of all patients, yet access is inconsistent.
-
Only 17% of EU countries effectively treat >80% of cancer patients.
-
Positioning alone takes 25–45 minutes per session, reducing capacity and delaying care.
Cancer Treatment Is in Crisis
What is Protonshot?
AiDDA's ProtonShot: Precision in Under 3 Minutes
-
Uses daily 3D x-rays, AI algorithms, and Monte Carlo dose simulations to align patients accurately.
-
Fits into existing hospital systems without workflow disruption.
Why It Matters
The AiDDA Advantage: Data-Driven, Patient-Centered
Key Benifits :-
-
<3-Minute Setup – 90% faster.
-
Up to 2x Throughput – More patients treated daily.
-
Dose-Guided Accuracy – Better targeting, fewer side effects.
-
Reduced Costs – Less dependency on expert operators.
-
Greater Access – Scales globally with minimal barriers.
Meet the AiDDA Founders
Experienced Minds Behind AiDDA
Daniele Farina
CEO
Executive MBA in AI, data, analytics.
Stefan Both
Founder & CSO
Medical physics professor, proton therapy chair.
Gabriel Guterres Marmitt
Founder & CTO
Expert in computational physics and MedTech systems.